Clicky

Practical Dermatology

Practical Dermatology A monthly publication that provides coverage of medical care, cosmetic advancements, and practice management for clinicians in the field. www.practicaldermatology.com

Practical Dermatology delivers real-world medical, cosmetic, and practice management advice for dermatologists and dermatology physician assistants. Readers recognize that Practical Dermatology’s unique editorial style cuts to the heart of the issues with expert opinions, timely coverage, clinical summaries, and high-quality supportive graphics. Whether readers are looking for insights on the late

Practical Dermatology delivers real-world medical, cosmetic, and practice management advice for dermatologists and dermatology physician assistants. Readers recognize that Practical Dermatology’s unique editorial style cuts to the heart of the issues with expert opinions, timely coverage, clinical summaries, and high-quality supportive graphics. Whether readers are looking for insights on the late

Operating as usual

Held for the first time in-person at the Hilton San Diego Bayfront, the Third Annual San Diego Dermatology Symposium (SD...
04/01/2022
Third Annual San Diego Dermatology Symposium (SDDS) Takes Place in Person - Practical Dermatology

Held for the first time in-person at the Hilton San Diego Bayfront, the Third Annual San Diego Dermatology Symposium (SDDS, March 11-13, 2022) offered networking, learning, and winning giveaways. Many attendees shared that this was their first live in-person meeting in a couple of years. Check out some highlights from the presentations https://hubs.ly/Q017dtkJ0

By Caroline Tan, MD, UCLA Dermatology Resident, PGY3 Held for the first time in-person at the Hilton San Diego Bayfront, the Third Annual San

Check out some of our latest videos: AD Treatment Guidelines; Cosmetic Derm Updates; Post-Resurfacing Care; Treating Nai...
03/31/2022

Check out some of our latest videos: AD Treatment Guidelines; Cosmetic Derm Updates; Post-Resurfacing Care; Treating Nails; Choosing the Right Biologic. Get treatment pearls for medical dermatology and aesthetic patients from leading dermatologists: https://practicaldermatology.com/meeting-coverage/aad-2022/laser-focus-optimizing-patient-care-for-best-results?c4src=meeting-coveragein-this-series

#dermatology #practicaldermatology #AAD2022 #eczema #psoriasis #aesthetics #nails #skinhealth #skincare

Did you attend the #AAD2022 Annual Meeting in Boston? There were so many great sessions and lots of interesting news. Wh...
03/29/2022
Practical Dermatology

Did you attend the #AAD2022 Annual Meeting in Boston? There were so many great sessions and lots of interesting news. What was your favorite session?
Be sure to check out all of our coverage of the meeting https://hubs.ly/Q016_mG60

#dermatology #practicaldermatology #AAD2022 #AAD #dermatologynews

Practical Dermatology is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in medical and cosmetic dermatology.

03/28/2022
Lilly's Olumiant Associated with Significant Hair Growth in Patients with Severe Alopecia Areata - Practical Dermatology

Olumiant (baricitinib) from Eli Lilly and Company produced significant scalp, eyelash, and eyebrow hair regrowth at 52 weeks, with nearly 75% of those who responded to Olumiant 4mg achieving 90% scalp coverage. The 52-week pooled findings were presented at the #AAD2022 Annual Meeting. FDA last month granted priority review for Olumiant as a potential first-in-disease medicine for severe #alopecia areata. https://hubs.ly/Q016XhtT0

Olumiant® (baricitinib) from Eli Lilly and company produced significant scalp, eyelash, and eyebrow hair regrowth at 52 weeks, with nearly 75

Aquavit Pharmaceuticals Inc. has submitted its IND for a new botulinum toxin (DTX-021) to the #FDA for approval. The com...
03/28/2022
Aquavit Submits NDA for New Neurotoxin - Practical Dermatology

Aquavit Pharmaceuticals Inc. has submitted its IND for a new botulinum toxin (DTX-021) to the #FDA for approval. The company also unveiled it Dermatox and Microtox programs at the #AAD22 Annual Meeting. https://hubs.ly/Q016VwWc0

Aquavit Pharmaceuticals, Inc. has submitted its IND for a new botulinum toxin (DTX-021) to the FDA for approval. The company also unveiled it Dermatox

03/28/2022
Opzelura Shows Benefit in 52-Week Phase 3 Vitiligo Study - Practical Dermatology

New 52-week results from the pivotal Phase 3 TRuE-V clinical trial program evaluating Incyte's topical JAK1/JAK2 inhibitor ruxolitinib cream (Opzelura) in adolescent and adult patients with nonsegmental #vitiligo show that twice daily application was associated with clinically meaningful facial and total body repigmentation. Presented in a late-breaking abstract session at the #AAD22 Annual Meeting, the data show a greater proportion of treated patients reached the facial and total body Vitiligo Area Scoring (F-VASI and T-VASI, respectively) endpoints at Week 52. https://hubs.ly/Q016VwW80

New 52-week results from the pivotal Phase 3 TRuE-V clinical trial program evaluating Incyte's topical JAK1/JAK2 inhibitor ruxolitinib cream (Opze

UCB presented 11 abstracts on bimekizumab in the treatment of adults with moderate to severe plaque #psoriasis at the #A...
03/28/2022
Long-Term Complete Skin Clearance Data for Bimekizumab in Moderate to Severe Plaque Psoriasis - Practical Dermatology

UCB presented 11 abstracts on bimekizumab in the treatment of adults with moderate to severe plaque #psoriasis at the #AAD22 Annual Meeting, including a late breaking oral platform presentation and 10 posters. The platform presentation detailed new analysis of pooled data from five bimekizumab Phase 3/3b clinical trials, which showed that more than 80 percent of patients who achieved PASI 100 at week 16 and entered the open-label extension studies maintained this response through two years, and no new safety signals were identified. https://hubs.ly/Q016Vs1H0

UCB presented 11 abstracts on bimekizumab in the treatment of adults with moderate to severe plaque psoriasis at the 2022 American Academy of Dermatol

Krystal Biotech Inc., presented more detailed results from the GEM-3 Phase 3 study of beremagene geperpavec (B-VEC), an ...
03/28/2022
New GEM-3 Phase 3 Results for B-VEC Presented at 2022 AAD Annual Meeting - Practical Dermatology

Krystal Biotech Inc., presented more detailed results from the GEM-3 Phase 3 study of beremagene geperpavec (B-VEC), an investigational, topical gene therapy for the treatment of dystrophic epidermolysis bullosa (DEB), at the #AAD22 Annual Meeting in Boston. https://hubs.ly/Q016V1J20

Krystal Biotech, Inc., presented more detailed results from the GEM-3 Phase 3 study of beremagene geperpavec (B-VEC), an investigational, topical gene

Allergan Aesthetics, an AbbVie company, is offering a new in-office rewards delivery system through its consumer loyalty...
03/26/2022
Get to Know Allergan Aesthetics’ Allē Flash - Practical Dermatology

Allergan Aesthetics, an AbbVie company, is offering a new in-office rewards delivery system through its consumer loyalty program, Allē—Allē Flash.
With a simple scan of a QR code at any participating provider’s office, Allē Members get the chance to be rewarded in real time as they check in for existing appointments at their participating provider’s office. https://hubs.ly/Q016R5ZK0

Allergan Aesthetics, an AbbVie company, is offering a new in-office rewards delivery system through its consumer loyalty program, Allē&md

03/26/2022

TMB-001, a topical isotretinoin formulated using Timber Pharmaceuticals’ patented IPEG™ delivery system, shows benefit in the treatment of congenital ichthyosis (CI), regardless of the subtype. Findings are being presented in a late-breaking presentation of a sub-analysis of the Phase 2b CONTROL study presented by Christopher Bunick, MD, PhD at the #AAD2022 Annual Meeting in Boston. https://hubs.ly/Q016QXQj0

03/26/2022
Poster: Interim Data Show Safety, Efficacy of Adbry for More than Three Years - Practical Dermatology

Interim data support the long-term safety and efficacy profile of Adbry (tralokinumab-ldrm) for up to 3.5 years in adult patients with moderate-to-severe atopic dermatitis (AD). Results were shared as a poster presentation at the #AAD2022 Annual Meeting. #eczema
https://hubs.ly/Q016Q_YC0

Interim data support the long-term safety and efficacy profile of Adbry™ (tralokinumab-ldrm) for up to 3.5 years in adult patients with moderate

Tremfya (guselkumab) from the Janssen Pharmaceutical Companies Of Johnson & Johnson provides a consistent, high degree o...
03/26/2022
Tremfya Safe, Effective Across Broad Patient Subpopulations Through Five Years: Analysis - Practical Dermatology

Tremfya (guselkumab) from the Janssen Pharmaceutical Companies Of Johnson & Johnson provides a consistent, high degree of durable skin clearance through 5 years in a majority of adult patients across broad subpopulations with moderate to severe plaque #psoriasis (PsO), based on an analysis of data from Phase 3 VOYAGE 1 and VOYAGE 2 clinical trials. #AAD2022 https://hubs.ly/Q016QZb30

Tremfya® (guselkumab) from the Janssen Pharmaceutical Companies of Johnson & Johnson provides a consistent, high degree of durable skin c

Galderma has launched Twyneo (tretinoin and benzoyl peroxide) Cream, 0.1%/3% in the US. Twyneo Cream features patented m...
03/26/2022
Galderma Launches Twyneo in the US - Practical Dermatology

Galderma has launched Twyneo (tretinoin and benzoyl peroxide) Cream, 0.1%/3% in the US. Twyneo Cream features patented microencapsulation technology that allows the delivery of two ingredients that have not been previously combined and enables their controlled release. It is the first and only 0.1% tretinoin and 3% benzoyl peroxide (BPO) 2-in-1 combination proven to rapidly treat moderate to severe facial #acne. #AAD2022 https://hubs.ly/Q016QX0B0

Galderma has launched Twyneo (tretinoin and benzoyl peroxide) Cream, 0.1%/3% in the US. The launch takes place during the annual meeting of the Americ

RedDress has begun shipments of their ActiGraft systems this week to multiple hospitals in Ukraine to help treat civilia...
03/26/2022
RedDress Ships ActiGraft to Ukraine to Treat Civilian Casualties - Practical Dermatology

RedDress has begun shipments of their ActiGraft systems this week to multiple hospitals in Ukraine to help treat civilian casualties as a result of Russian attacks. An initial shipment of 400 units of the blood clotting wound care system is en route. https://hubs.ly/Q016Q-Hd0

RedDress has begun shipments of their ActiGraft systems this week to multiple hospitals in Ukraine to help treat civilian casualties as

New issue alert! Check out the latest issue of Practical Dermatology - now available online! Get updates on the state of...
03/25/2022

New issue alert! Check out the latest issue of Practical Dermatology - now available online! Get updates on the state of practice in dermatology—from advocacy to M&A activity to emerging qualifications. Plus, tips on improving patient care. https://hubs.ly/Q016PldT0

#dermatology #practicaldermatology #newissue #newcontent #stateofdermatology #weekendreading

Excited to be at #aad2022 -stay tuned for our coverage of the meeting and new video series coming soon!
03/25/2022

Excited to be at #aad2022 -stay tuned for our coverage of the meeting and new video series coming soon!

Long-time Practical Dermatology® Digital Practice editor Mark D. Kaufmann, MD, FAAD, is the new President of the  Americ...
03/25/2022
Mark D. Kaufmann, MD, FAAD Takes the Helm at AAD - Practical Dermatology

Long-time Practical Dermatology® Digital Practice editor Mark D. Kaufmann, MD, FAAD, is the new President of the American Academy of Dermatology.
Dr. Kaufmann, a clinical professor of the Department of Dermatology Icahn School of Medicine at Mount Sinai in New York, will begin his one-year term immediately following the #AAD2022 annual; meeting, which takes place in Boston from March 25 – 29.
https://hubs.ly/Q016NDrS0

New officers, board members announced at AAD annual meeting

Are you attending #aad2022? Visit us at Booth 2223
03/25/2022

Are you attending #aad2022? Visit us at Booth 2223

The FDA has cleared granted 510(k) clearance to Cutera's AviClear acne device.This is the first energy device to receive...
03/25/2022

The FDA has cleared granted 510(k) clearance to Cutera's AviClear acne device.
This is the first energy device to receive a nod for the treatment of mild, moderate, and severe acne.
AviClear targets acne at the source by selectively targeting the sebocytes and suppressing sebum production. In addition to reducing existing acne, clinical trials show that future breakout episodes are shorter, less intense, and more infrequent following the AviClear procedure.
https://hubs.ly/Q016MWPd0

#dermatology #practicaldermatology #acne #FDAapproval #AviClear

The American Academy of Dermatology (AAD) in collaboration with Johnson & Johnson Consumer Health and the Janssen Pharma...
03/23/2022
New AAD, Industry Collab to Increase Number of Black, Latino, and Indigenous Physicians in Dermatology - Practical Dermatology

The American Academy of Dermatology (AAD) in collaboration with Johnson & Johnson Consumer Health and the Janssen Pharmaceutical Companies Of Johnson & Johnson is launching “Pathways: Inclusivity in Dermatology” to increase the number of practicing dermatologists in the US who are from the Black, Latino, and Indigenous communities, which are underrepresented minorities (URM) in medicine. The plan is to double representation in next 5 years. Learn what steps they're taking: https://hubs.ly/Q016BwSh0

#dermatology #practicaldermatology #AAD2022 #DEI #diversityinmedicine #inclusion

“Pathways: Inclusivity in Dermatology” aims to increase the number of practicing dermatologists in the U.S. who are from the Black, Latino, and Indigenous communities, which are underrepresented minorities in medicine.

03/22/2022
Dove, Crown Coalition Applaud U.S. House of Representatives for Passing Crown Act - Practical Dermatology

Dove, Crown Coalition Applaud U.S. House of Representatives for Passing Crown Act:
The CROWN Act legislation (H.R. 2116) provides legal protection from hair discrimination based on the texture of natural hair or hairstyles such as braids, locs, twists, bantu knots, and Afros. https://hubs.ly/Q016rSGZ0

The CROWN Act legislation (H.R. 2116) provides legal protection from hair discrimination based on the texture of natural hair or hairstyles such as braids, locs, twists, bantu knots, and Afros.

In an effort to deliver outstanding comprehensive care and to employ revolutionary approaches to novel therapeutics arou...
03/22/2022
Mount Sinai Health System Launches Alopecia Areata Center of Excellence - Practical Dermatology

In an effort to deliver outstanding comprehensive care and to employ revolutionary approaches to novel therapeutics around alopecia areata, the Mount Sinai Health System has launched the Alopecia Areata Center of Excellence. Under the leadership of Director Emma Guttman-Yassky, MD, PhD, the new Center will be fully integrated within the state-of-the art Laboratory for Inflammatory Skin Diseases, and will fall under the umbrella of the Kimberly and Eric J. Waldman Department of Dermatology at Mount Sinai.
The creation of this new Alopecia Areata Center of Excellence was made possible by a generous $5 million gift from the Pure Family.
https://hubs.ly/Q016rMyK0

The creation of the new Alopecia Areata Center of Excellence was made possible by a generous $5 million gift from the Pure Family.

The majority of liability claims due to a cutaneous laser surgery device between 2012 and 2020 involved a non-physician ...
03/21/2022
Study: Laser Surgery Lawsuits Less Likely with Physician Operators - Practical Dermatology

The majority of liability claims due to a cutaneous laser surgery device between 2012 and 2020 involved a non-physician operator, according to a new study in the March 2022 issue of Dermatologic Surgery.
Researchers analyzed cases of liability claims due to a cutaneous laser surgery device that took place in the United States from 2012 to 2020 and found that 71 percent of 69 claims involved a non-physician operator. Laser hair removal was most litigated (44 cases, 64%), followed by laser skin rejuvenation (20 cases, 30%), the study showed.
https://hubs.ly/Q016mtRZ0

Fully 71 percent of 69 liability claims due to a cutaneous laser surgery device involved a non-physician operator.

Address

1008 Upper Gulph Rd
Wayne, PA
19087

Telephone

(484) 581-1865

Alerts

Be the first to know and let us send you an email when Practical Dermatology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Practical Dermatology:

Videos

Nearby media companies


Other Media/News Companies in Wayne

Show All

Comments

We are proud to partner with Practical Dermatology as we continue our Medical Education Series, hosted by geneticist Thomas Hitchcock, Ph.D., Chief Science Officer at Crown Laboratories. Visit PD's online portal today to access our range of medical education resources, including: * Our Beauty & the Bacteria docuseries, which takes you inside the world of the skin microbiome; * The Skin Science Podcast, a monthly podcast that covers hot topics relating to skin health; and, * Several articles penned by Dr. Hitchcock that will challenge the way you think about skin microbiome care. #OneCrown #SkinScienceforLife #PracticalDermatology #medicaleducation #science #podcast #docuseries #whitepapers #skinmicrobiome #skincare #dermatology #aesthetics #innovation https://fal.cn/3nqxr
Practical Dermatology highlighted the Outstanding Leadership in Dermatology Education and Research Award presented to Joel L. Cohen, MD at ODAC 2022! Congratulations again, Dr. Cohen! https://practicaldermatology.com/news/odac-and-jdd-honor-dr-joel-l-cohen?c4src=home:feed
#ASDSMembers in the News — Mathew Avram, MD, JD, sat down with Practical Dermatology to reflect on dermatology in 2021.
Dr. Amy Brodsky has contributed another article to Practical Dermatology, this time focused on #sunscreen safety. Her key takeaways: ☀️ Sunscreens are safe! If you are concerned about ingredients, then use ones with #zinc oxide and #titanium dioxide. ☀️ Sunscreen must be applied correctly in order to work (the sprays can be tricky!) ☀️ Sunscreen is only one part of a good sun safety plan (hint- seek shade!) ☀️ Kids need to know sun safety! #beasunhero https://practicaldermatology.com/articles/2021-dec/update-on-uv-safety?c4src=issue:feed
Great to see DermTech featured in Practical Dermatology on technology for detecting skin cancer. Early detection is key when it comes to ending melanoma deaths and the DermTech Melanoma Test is the only non-invasive test to accurately detect the presence of this deadly skin cancer. And a great reminder for us all to always check our skin, use sun protection and see a derm regularly! https://practicaldermatology.com/articles/2021-sept/using-technology-to-detect-skin-cancer-profile-lesions-and-streamline-your-practice?c4src=home:feed
As augmented intelligence evolves, here are 7 things every dermatologist should know about its potential and its limitations. Practical Dermatology https://practicaldermatology.com/articles/2021-sept/what-every-dermatologist-should-know-about-ai/pdf
Don't miss the most recent episodes of Coping with COVID-19! Our panel of aesthetic physicians reconvened for an update on current safety protocols in their practices, their thoughts on mask and vaccine mandates, travel to lives meetings, and more! Michael Gold, MD of Gold Skin Care Center led the discussions with Dr Doris Day; Dr. Mark S. Nestor; Dr. Joel Schlessinger; and Dr. Amy Taub https://hubs.ly/H0VP33t0 #aesthetics #dermatology #plasticsurgery #covid #copingwithcovid19 #safetyprotocols #masks #vaccines #meetings #livemeetings #dermatologists #plasticsurgeons #aestheticphysicians Practical Dermatology
“Forget textbooks, lectures, and labs. Future dermatologists may soon be learning in a whole new (and likely much more fun) way.” Practical Dermatology explores how Top Derm’s game design can help improve the way #dermatologists sharpen their skills and stay up to date. Read more: http://ow.ly/BxNV50FWcKT
Curious what people are saying about our new medical game Top Derm? Dr. Shraddha Desai joins Practical Dermatology’s DermWireTV to discuss our latest medical video game, Top Derm, and shares the benefits of accessing dermatology resources from her mobile phone. “I find it enjoyable. You don’t have to lug around your book or your journal, or anything with you. It’s something you carry around with you all the time” Hear what else Dr. Desai has to say and watch the entire episode here: http://ow.ly/flXA50FKog9
It’s a great time to be a pedi derm! Wondering just how great? Hear it firsthand from SPD’s own Dr. Mercedes Gonzalez when she spoke to Practical Dermatology’s DermWireTV about the 2020 Pediatric Dermatology Physician Compensation Report. Watch the full clip here: http://bit.ly/DWTVsalaries
“Each of us has biases, and an important first step is to acknowledge what those are and be introspective about how we can address them for the betterment of ourselves and those that we interact with, particularly our patients,” – Dr. Nada Elbuluk, Director of Clinical Impact at VisualDx. Learn more in Practical Dermatology on how healthcare professionals can overcome cognitive biases: https://practicaldermatology.com/articles/2021-may/confronting-biases-to-improve-patient-care?c4src=home:feed
Director of Clinical Impact Dr. Nada Elbuluk writes for Practical Dermatology about Confronting Biases to Improve Patient Care - "Cognitive biases can lead to inaccurate diagnoses and a negative impact on patient care. But it’s possible to overcome the obstacles." https://bit.ly/3od2s6S #projectIMPACT